Brendan Delaney
Director/Board Member chez BEYONDSPRING INC.
Fortune : 46 800 $ au 31/03/2024
Profil
Brendan Delaney is currently a Director at BeyondSpring Pharmaceuticals, Inc., an Independent Director at BeyondSpring, Inc., and a Director at MJH Healthcare Holdings LLC.
He was previously the President & Chief Executive Officer at Aadi Subsidiary, Inc., and later became the President, Chief Executive Officer & Director at Aadi Bioscience, Inc. He also held positions as Director-Global Chronic Myeloid Leukemia Franchise at Novartis Oncology, Inc., VP-US Commercial Hematology & Oncology at Celgene Corp., and Chief Commercial Officer at Immunomedics, Inc. and Constellation Pharmaceuticals, Inc. Mr. Delaney received his undergraduate degree from Rutgers State University of New Jersey and his MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AADI BIOSCIENCES, INC.
0,08% | 01/03/2023 | 20 000 ( 0,08% ) | 46 800 $ | 31/03/2024 |
BEYONDSPRING INC.
-.--% | 01/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Brendan Delaney
| Sociétés | Poste | Début |
|---|---|---|
| BEYONDSPRING INC. | Director/Board Member | 14/07/2021 |
BeyondSpring Pharmaceuticals, Inc.
 BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The private company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Director/Board Member | - |
MJH Healthcare Holdings LLC
 MJH Healthcare Holdings LLC Internet Software/ServicesTechnology Services MJH Healthcare Holdings LLC operates as a medical media company. Its services include creative, interactive, live events, clinical communication, promotional education, and market access. The company is headquartered in Cranbury, NJ. | Director/Board Member | - |
Anciens postes connus de Brendan Delaney
| Sociétés | Poste | Fin |
|---|---|---|
| AADI BIOSCIENCE, INC. | Chief Executive Officer | 03/03/2023 |
| CONSTELLATION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/09/2021 |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | 01/01/2021 |
| CELGENE | Corporate Officer/Principal | 01/11/2017 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/01/2011 |
Formation de Brendan Delaney
| Rutgers State University of New Jersey | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BEYONDSPRING INC. | Health Technology |
| AADI BIOSCIENCE, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
BeyondSpring Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The private company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Health Technology |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA. | Health Technology |
MJH Healthcare Holdings LLC
MJH Healthcare Holdings LLC Internet Software/ServicesTechnology Services MJH Healthcare Holdings LLC operates as a medical media company. Its services include creative, interactive, live events, clinical communication, promotional education, and market access. The company is headquartered in Cranbury, NJ. | Technology Services |
